Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Regan

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Nature Microbiology|October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trialManish C Choudhary, Kara W Chew, Rinki Deo, et al.
The Journal of Pediatrics|September 21, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
The Journal of Pediatrics|September 24, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
The Journal of Pediatrics|August 23, 2020
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune ResponsesLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 OutcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody TherapyManish C Choudhary, Kara W Chew, Rinki Deo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody ResponsesMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
JCI Insight|October 10, 2022
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variantMichael S Seaman, Mark J Siedner, Julie Boucau, et al.
Nature Microbiology|October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trialManish C Choudhary, Kara W Chew, Rinki Deo, et al.
The Journal of Pediatrics|September 21, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
The Journal of Pediatrics|September 24, 2020
ReplyLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
The Journal of Pediatrics|August 23, 2020
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune ResponsesLael M Yonker, Anne M Neilan, Yannic Bartsch, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 OutcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Pageof 6